$0.60
▲ +$0.00
(+0.00%)
Vol 1K
2
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$13.1M
ROE
-26.5%
Margin
-2283.4%
D/E
0.00
Beta
0.50
52W
$1–$2
Wall Street Consensus
6 analysts · May 20250
Strong Buy
0
Buy
3
Hold
1
Sell
2
Strong Sell
0.0%
Buy Rating
Price Chart
Similar Stocks
RNAZ
Transcode Therapeutics Inc
$6.3M
CELZ
Creative Medical Technology Holdings Inc
$5.1M
PMCB
PharmaCyte Biotech Inc
$7.3M
LIMN
Liminatus Pharma Inc
$16.5M
TCRT
Alaunos Therapeutics Inc
$7.2M
XBIO
Xenetic Biosciences Inc
$5.0M
CDIO
Cardio Diagnostics Holdings Inc
$4.9M
BRTX
BioRestorative Therapies Inc
$10.4M
ERNA
Ernexa Therapeutics Inc
$9.4M
Earnings
Beat rate: 75.0%
Next Report
May 06, 2026
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | — | — | — |
| Dec 2024 | $-0.10 | $-0.06 | +$0.04 |
| Sep 2024 | $-0.18 | $-0.01 | +$0.17 |
| Jun 2024 | $-0.52 | $0.16 | +$0.68 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -8.1% | -167.8% | -8.1% | -8.1% | -8.1% | -26.5% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | -2283.4% | -2283.4% | -2283.4% | -2283.4% | -2283.4% |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 3.63 | 3.68 | 3.63 | 3.63 | 3.63 | 2.65 |
Key Ratios
ROA (TTM)
-18.0%
P/S (TTM)
4.09
P/B
1.3
EPS (TTM)
$-0.26
CF/Share
$-12.25
Rev Growth 3Y
-83.4%
52W High
$1.96
52W Low
$0.90
$0.90
52-Week Range
$1.96
How does SYBX compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
SYBX valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
4.1
▼
68%
below
peers
(12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
1.3
▼
48%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
SYBX profitability vs Biotechnology peers
ROE
-26.5%
▲
61%
above
peers
(-67.3%)
vs Peers
vs Industry
Top tier
Net margin
-2283.4%
▼
696%
below
peers
(-286.8%)
vs Peers
vs Industry
Weak
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-18.0%
▲
61%
above
peers
(-46.7%)
vs Peers
vs Industry
Top tier
SYBX financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
2.7
▼
40%
below
peers
(4.4)
vs Peers
vs Industry
Low liquidity
Beta
0.5
▼
48%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
SYBX fundamentals radar
SYBX
Peer median
Industry
SYBX profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
SYBX vs peers: key metrics
Latest News
No related news yet